GA

Aviceda Announces Successful Submission of an Investigational New Drug (IND) and Fast Track Designation (FTD) Application for AVD-104 for the Treatment of Geographic Atrophy Associated with Age-Related Macular Degeneration (AMD)

Retrieved on: 
Monday, March 20, 2023
Biotechnology, FDA, Health, Pharmaceutical, Optical, GLP, Good laboratory practice, AMD, Toxicity, GA, Fibrosis, Investigational New Drug, Animal, MD, Patient, Rabbit, Entrepreneurship, Therapy, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, IND, Food, Eye disease, Safety, Pharmaceutical industry, Aviceda

Aviceda previously announced the successful completion of IND-enabling Good Laboratory Practice (GLP) toxicity studies that showed positive safety data for multiple well-tolerated doses of AVD-104.

Key Points: 
  • Aviceda previously announced the successful completion of IND-enabling Good Laboratory Practice (GLP) toxicity studies that showed positive safety data for multiple well-tolerated doses of AVD-104.
  • This included dose-range finding studies in non-human primates (NHPs) and rabbits (80 total animals), to support continued development and the initiation of human clinical trials.
  • “With only one currently approved therapy for the treatment of GA, there is still a significant unmet medical need for patients with this condition.
  • We anticipate beginning our Phase 2 trial as soon as possible after FDA review.

Voluntary Recall of One Lot of Kaytee® Wild Bird Food Birders’ Blend, 8 Lb. Bag, Due to Elevated Levels of Aflatoxin

Retrieved on: 
Saturday, March 18, 2023
Family, Retail, Other Consumer, Consumer, Seniors, Specialty, Pets, Food, CST, Regulation of tobacco by the U.S. Food and Drug Administration, Southeastern United States, GA, Safety

The affected wild bird product was packaged in clear plastic bags and shipped to ACE Hardware Distribution Centers in AL, FL, and GA, which service neighborhood hardware stores in the Southeastern United States.

Key Points: 
  • The affected wild bird product was packaged in clear plastic bags and shipped to ACE Hardware Distribution Centers in AL, FL, and GA, which service neighborhood hardware stores in the Southeastern United States.
  • Retailers who received the affected wild bird product have been contacted and asked to pull them from their inventory and shelves.
  • No adverse health effects have been reported with respect to the affected wild bird product at this time.
  • Consumers who have purchased the recalled wild bird product should return it to the place of purchase for a full refund.

Verizon continues to upgrade Atlanta's best network

Retrieved on: 
Tuesday, March 14, 2023
High-pass filter, U.S. Route 41 in Georgia, IPhone, Truist Park, Business, Television, GA, Partnership, Operation, Battery, Internet, Travel, RootMetrics, Tablet, Cable television, Mobile phone, Verizon Communications, Engineering, Cumberland Mall

ATLANTA, March 14, 2023 (GLOBE NEWSWIRE) -- Customers and visitors to Atlanta, GA have the best experience when using the Verizon network, according to the nation’s most rigorous scientific testing company RootMetrics®.

Key Points: 
  • ATLANTA, March 14, 2023 (GLOBE NEWSWIRE) -- Customers and visitors to Atlanta, GA have the best experience when using the Verizon network, according to the nation’s most rigorous scientific testing company RootMetrics®.
  • “Our network engineers work tirelessly to ensure we can provide the most reliable connections across Atlanta.
  • These top marks are a result of months of deploying new enhancements in the network for those who live in and visit the Atlanta area.
  • Tested with best commercially available smartphones on three mobile networks across all available network types.

LumiThera Announces Sustained Vision Improvement for 24 months in Dry Age-Related Macular Degeneration Subjects from US LIGHTSITE III Clinical Trial Data

Retrieved on: 
Wednesday, March 15, 2023
General Health, Medical Devices, Health, Optical, Clinical Trials, Arm, PBM, Stanford University, Duke University, USS Valeda (SP-592), GA, European, Visual acuity, OCT, Ophthalmology, Patient, Master of Science, MBA, Disease, AMD, Safety, Paratriathlon, Geographic atrophy, Letter, HIV disease progression rates, Pharmaceutical industry, Medical device, MD

LumiThera Inc., a medical device company offering photobiomodulation (PBM) treatment for ocular damage and disease, today announced the 24-month data from its LIGHTSITE III, multi-center clinical trial which demonstrated sustained vision improvement in dry Age-Related Macular Degeneration (AMD) subjects treated with the Valeda® Light Delivery System.

Key Points: 
  • LumiThera Inc., a medical device company offering photobiomodulation (PBM) treatment for ocular damage and disease, today announced the 24-month data from its LIGHTSITE III, multi-center clinical trial which demonstrated sustained vision improvement in dry Age-Related Macular Degeneration (AMD) subjects treated with the Valeda® Light Delivery System.
  • LIGHTSITE III, a prospective, double-masked, randomized, multi-center clinical trial, was conducted at ten leading US retinal centers and enrolled 100 subjects with early to intermediate dry AMD.
  • The last treatment was administered at 21 months and the last follow-up visit was at 24 months.
  • At 24 months there were minimal safety risks and high patient compliance; 80% of the patients completed the trial.

Publications - Coordinators' decisions 2023 - Committee on Budgets

Retrieved on: 
Wednesday, March 15, 2023
Tourism, Parliament, SV, Food safety, Danish, PT, COVID-19, FI, Democrat, Rural development, Open data portal, Artificial intelligence, EN, GA, LV, Employment, Committee, Education, Workshop, PL, EL, Home, RO, Justice, Member of the European Parliament, European Parliament, Contract, EP, Culture, SK, MT, Cancer, DA, BG, Event, Budget, PDF, DE, CS, Publication, European, Public health, News, LT, Newsletter, Research, SL, HU, FR, Customer service, Online shopping, Furniture, Television, Typesetting, Airline, Cosmetics, Consumer electronics, Construction, Whaling, Car rental, Financial adviser, Publishing, Employment agency, Dairy, Tax advisor, Livestock, Vaccine, Information technology, Residential care, Fair, Risk management, Management, Pegasus, Animal

Access to page content (press "Enter")

Key Points: 
  • Access to page content (press "Enter")
    Direct access to language menu (press "Enter")
    Direct access to search menu (press "Enter")
    EN - English
    BG - български
    ES - español
    CS - čeština
    DA - dansk
    DE - Deutsch
    ET - eesti keel
    EL - Ελληνικά
    EN - English
    FR - français
    GA - Gaeilge
    HR - hrvatski
    IT - italiano
    LV - latviešu valoda
    LT - lietuvių kalba
    HU - magyar
    MT - Malti
    NL - Nederlands
    PL - polski
    PT - português
    RO - română
    SK - slovenčina
    SL - slovenščina
    FI - suomi
    SV - svenska
    News
    MEPs
    About Parliament
    Plenary
    Committees
    Delegations
    Other websites
    Other websites
    News
    MEPs
    About Parliament
    Plenary
    Committees
    Delegations
    Multimedia Centre
    President’s website
    Secretariat-general
    Think tank
    EP Newshub
    At your service
    Visits
    Legislative train
    Contracts and Grants
    Register
    Open Data Portal
    Committees
    European Parliament
    Search
    Search
    Please fill this field
    BUDG
    European Parliament
    Search
    Menu
    Choose your committee
    Choose your committee
    All committees - Homepage
    Foreign Affairs
    Human Rights
    Security and Defence
    Development
    International Trade
    Budgets
    Budgetary Control
    Economic and Monetary Affairs
    Tax Matters
    Employment and Social Affairs
    Environment, Public Health and Food Safety
    Industry, Research and Energy
    Internal Market and Consumer Protection
    Transport and Tourism
    Regional Development
    Agriculture and Rural Development
    Fisheries
    Culture and Education
    Legal Affairs
    Civil Liberties, Justice and Home Affairs
    Constitutional Affairs
    Women’s Rights and Gender Equality
    Petitions
    Beating Cancer
    COVID-19 pandemic: lessons learned and recommendations for the future
    Special Committee on foreign interference and disinformation, and on strengthening integrity in the EP
    Foreign Interference in all Democratic Processes in the European Union, including Disinformation
    Artificial Intelligence in a Digital Age
    Protection of Animals during Transport
    Use of Pegasus and equivalent surveillance spyware
    Go to the page
    BUDG
    Home
    Highlights
    Members
    Press releases
    Newsletters
    Publications
    Subject files
    Meetings
    Meeting documents
    Webstreaming
    Votes
    Minutes
    Documents
    Latest documents
    Motions for Resolution
    Search
    Work in progress
    Events
    Hearings
    Workshops
    Missions
    Other events
    Supporting analyses
    Latest documents
    Search
    Presentation
    Budgetary procedures
    2024 procedure
    2023 procedure
    2022 procedure
    2021 procedure
    2020 procedure
    2019 procedure
    About
    Go back
    BUDG
    Home
    Publications
    Coordinators' decisions 2023
    Coordinators' decisions 2023
    Share this page on Facebook
    Share this page on Twitter
    Share this page on LinkedIn
    1 March
    (PDF - 237 KB)
    31 January
    (PDF - 438 KB)

Fresenius Kidney Care Reunites with Food Is Medicine Coalition on Mission to Expand Access to Medically Tailored Meals

Retrieved on: 
Monday, March 13, 2023
Prevalence, ESRD, Education, MTM, White House conference, Knowledge, United States Department of Health and Human Services, CMS, Diet, Disbursement Acceleration Program, CKD, Medicare, GA, Conference, Dialysis, Centers for Disease Control and Prevention, Exercise, Chronic kidney disease, Quality of life, Research, Patient, Community Health Accreditation Program, Medicine, School health and nutrition services, Food, Diagnosis, Methyltrimethoxysilane, Kidney, Kidney disease, Kidney failure, FIMC, COVID-19, Partnership, Donation, Pharmaceutical industry, Dietary supplement, Medicaid, Health, Hunger

WALTHAM, Mass., March 13, 2023 /PRNewswire/ -- Fresenius Kidney Care, the nation's leader in kidney care services and education, renewed its support for the Food Is Medicine Coalition (FIMC) to help those living with severe illness eat and live better. Fresenius Kidney Care is donating $150,000 to FIMC to expand access to medically tailored meals (MTMs) through the FIMC Accelerator Program and to support the development of an accreditation program to ensure fidelity to the quality standards of the FIMC medically tailored meal model.

Key Points: 
  • Fresenius Kidney Care is donating $150,000 to FIMC to expand access to medically tailored meals (MTMs) through the FIMC Accelerator Program and to support the development of an accreditation program to ensure fidelity to the quality standards of the FIMC medically tailored meal model.
  • March is National Kidney Month, when kidney health advocates such as Fresenius Kidney Care raise awareness about the prevalence of chronic kidney disease (CKD).
  • "We're committed to helping patients living with CKD approach their care holistically, and providing medically tailored meals can help improve their outcomes."
  • With support from Fresenius Kidney Care, FIMC is poised to further drive broader access to medically tailored meals across the country by leveraging this widespread momentum for "food is medicine" interventions.

Band of Coders acquires UX/UI design company, Toolbox No. 9

Retrieved on: 
Friday, March 10, 2023
Acquisition, Feature Selection Toolbox, UI, Life, UX, Senior, Culture, Engineering, API, GA, Software, LP, Video game, Toolbox, Programmer

ATLANTA, March 10, 2023 /PRNewswire-PRWeb/ -- Band of Coders, LP, a leading software development and engineering agency, announces the acquisition of Atlanta-based Toolbox No. 9, Inc. ("Toolbox"): a company specializing in User Experience & User Interface Design and Development (UX/UI) for website and software applications. Combining Band of Coders' engineering services with Toolbox's design expertise, the acquisition allows both companies to offer more balanced, full-scale services to new and existing customers.

Key Points: 
  • A national leader in software development, Band of Coders will now offer premier UX and UI design through the Toolbox brand
    ATLANTA, March 10, 2023 /PRNewswire-PRWeb/ -- Band of Coders, LP, a leading software development and engineering agency, announces the acquisition of Atlanta-based Toolbox No.
  • 9, Inc. ("Toolbox"): a company specializing in User Experience & User Interface Design and Development (UX/UI) for website and software applications.
  • Combining Band of Coders' engineering services with Toolbox's design expertise, the acquisition allows both companies to offer more balanced, full-scale services to new and existing customers.
  • According to Bobby John, CEO of Band of Coders: "Band of Coders is always listening to our clients' needs and evolving our services to address them.

Anti-Properdin Antibody (NM3086) Demonstrates Efficacy in a Primate Model of Wet-AMD and Dry-AMD

Retrieved on: 
Monday, March 6, 2023
AP, Geographic atrophy, Charles River Laboratories, Blood, Complement, Left, Bleeding, Growth, Animal, Choroidal neovascularization, Neovascularization, AMD, Therapy, GA, Retina, Disease, Fluorescein angiography, FDA, CNV, Observation, Pharmaceutical industry, Fibrosis

CLEVELAND, March 06, 2023 (GLOBE NEWSWIRE) -- NovelMed Therapeutics announced today that NM3086, the lead clinical asset in its Properdin-associated Alternative Pathway (AP) program, demonstrated favorable efficacy in an animal model of neovascular age-related macular degeneration (AMD) in rhesus monkeys. This animal model is characterized not only by the abnormal growth of new blood vessels behind the retina, as shown in Figure 1, but also by retinal fibrosis and vascular hemorrhage, which are the critical characteristics of Wet-AMD, Dry-AMD, and GA. While it is difficult to extrapolate the visual acuity score in animals, the damage prevented by NM3086 in this model suggests the drug's efficacy in treating the disease.

Key Points: 
  • The lead drug candidate NM3086 prevented hemorrhage, fibrosis, and neovascularization in a 28-day disease model in rhesus monkeys.
  • While it is difficult to extrapolate the visual acuity score in animals, the damage prevented by NM3086 in this model suggests the drug's efficacy in treating the disease.
  • Figure 1: Fluoresceine angiogram data from three animals treated with NM3086 (bottom) and three that received placebo control.
  • Scientists of Charles River Laboratories established a preclinical Choroidal Neovascularization (CNV) efficacy model in rhesus monkeys.

Unibloc Hygienic Technologies Acquires Metaltech Precision Engineers, An Experienced Provider of CNC Machining Services

Retrieved on: 
Thursday, March 9, 2023
Engineering, Chemicals, Plastics, Manufacturing, Construction & Property, Building Systems, Other Manufacturing, Machinery, UHT, Poultry, Meat, Specialization, Acquisition, CNC, Partnership, Food, GA, Pine River Capital Management, Investment, Transport, Metaltech, Atenolol, Bolney

Unibloc Hygienic Technologies (UHT, www.unibloctech.com ), a global provider of hygienic positive displacement pumps, air-operated double diaphragm (AODD) pumps, drum pumps, and other flow control products, today announced the acquisition of Metaltech Precision Engineers Ltd. Metaltech, a UK-based CNC machining services provider, enjoys a nearly 50-year operating history as a critical supply chain partner to the hygienic flow control industry.

Key Points: 
  • Unibloc Hygienic Technologies (UHT, www.unibloctech.com ), a global provider of hygienic positive displacement pumps, air-operated double diaphragm (AODD) pumps, drum pumps, and other flow control products, today announced the acquisition of Metaltech Precision Engineers Ltd. Metaltech, a UK-based CNC machining services provider, enjoys a nearly 50-year operating history as a critical supply chain partner to the hygienic flow control industry.
  • Metaltech, founded in 1976, is a precision engineering and CNC machining services vendor with a specialization in the hygienic flow control sector.
  • Metaltech provides machining for a wide range of UHT’s hygienic pumps that serve the food, beverage, bakery/confection, meat and poultry, brewery, pharmaceutical and transportation markets globally.
  • This is the third acquisition in 18 months for Unibloc Hygienic Technologies, a May River Capital portfolio company.

RG6501 (OpRegen®) Phase 1/2a Results to Be Featured at 2023 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting in Presentation by Eyal Banin, M.D., Ph.D.

Retrieved on: 
Monday, March 6, 2023
Health, Stem Cells, Health Technology, Clinical Trials, Optical, Biotechnology, Geographic atrophy, Hadassah Medical Center, TASE, Research, OCT, Retinal, AMD, Therapy, Patient, Ernest, GA, University Medical Center, Eye, Lineage Cell Therapeutics, ARVO, Roche, NYSE American, Medical imaging, Pharmaceutical industry, Ophthalmology, Genentech

The meeting will be held April 23 – 27, 2023 at the Ernest N. Morial Convention Center in New Orleans, LA.

Key Points: 
  • The meeting will be held April 23 – 27, 2023 at the Ernest N. Morial Convention Center in New Orleans, LA.
  • RG6501 (OpRegen) is a retinal pigment epithelium cell transplant therapy currently in development for the treatment of geographic atrophy secondary to age-related macular degeneration (AMD).
  • The Association for Research in Vision and Ophthalmology, Inc. (ARVO) was founded in 1928 in Washington, DC by a group of 73 ophthalmologists.
  • ARVO is the largest and most respected eye and vision research organization in the world.